Table 2 Meta analysis of the association of VDR BsmI,FokI, TaqI and ApaI gene polymorphisms with DN risk

3

1.13 [0.72, 1.75]

0.60

2

0.99 [0.85, 1.16]

0.93

1

1.75 [1.08, 2.86]

0.02

3

0.98 [0.74, 1.30]

0.89

2

0.96 [0.72, 1.28]

0.77

1

4.78 [0.24, 93.31]

0.30

3

0.84 [0.53, 1.33]

0.45

2

0.99 [0.79, 1.24]

0.93

1

0.55 [0.32, 0.94]

0.03

4

0.88 [0.52, 1.48]

0.62

3

1.19 [0.81, 1.73]

0.38

1

0.33 [0.18, 0.61]

0.0004

4

0.92 [0.50, 1.71]

0.80

3

1.24 [0.74, 2.05]

0.41

1

0.29 [0.12, 0.72]

0.008

4

1.18 [0.52, 2.72]

0.69

3

0.78 [0.59, 1.03]

0.08

1

5.00 [1.61, 15.56]

0.005

4

0.96 [0.84, 1.11]

0.62

2

0.92 [0.79, 1.08]

0.30

2

1.46 [0.63, 3.38]

0.37

4

0.97 [0.79, 1.20]

0.77

2

0.89 [0.71, 1.11]

0.31

2

2.21 [1.05, 4.67]

0.04

4

1.08 [0.83, 1.40]

0.56

2

1.10 [0.82, 1.48]

0.52

2

1.01 [0.58, 1.77]

0.97

4

0.94 [0.83, 1.07]

0.35

1

0.97 [0.84, 1.13]

0.73

3

0.89 [0.72, 1.10]

0.26

4

0.89 [0.72, 1.11]

0.31

1

0.93 [0.74, 1.18]

0.57

3

0.73 [0.43, 1.23]

0.24

4

1.06 [0.87, 1.28]

0.58

1

0.99 [0.77, 1.29]

0.96

3

1.14 [0.85, 1.53]

0.37